查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954652

全球肺活量計市場：市場規模、佔有率、成長率、行業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034 年）

Spirometers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 139 Pages | 商品交期: 請詢問到貨日

價格

肺活量計市場成長驅動因子

2025 年，全球肺活量計（肺容量計）市值為 6.7985 億美元。預計該市場將從 2026 年的 7.1661 億美元增長到 2034 年的 11.2292 億美元，在預測期（2026-2034 年）內複合年增長率 (CAGR) 為 6.63%。

2025 年，北美地區佔肺活量計市場的主導地位，市佔率為 50.46%，這得益於該地區呼吸系統疾病的高發生率和完善的醫療保健基礎設施。

肺活量計是一種診斷醫療設備，透過測量吸入和呼出的氣體量來評估肺功能。 呼出氣量。 肺功能測定在氣喘、慢性阻塞性肺病 (COPD) 和囊性纖維化等呼吸系統疾病的診斷和治療中發揮著至關重要的作用。根據國際呼吸學會論壇 (2023) 的數據，全球約有 3.34 億人患有氣喘，超過 6,500 萬人患有 COPD，凸顯了對肺功能測定設備日益增長的需求。

由於肺功能檢測 (PFT) 機構的暫時關閉，COVID-19 疫情對市場造成了負面影響，但隨著醫療機構的重新開放和呼吸系統診斷需求的增加，市場在 2021 年至 2022 年間開始復甦。

肺功能測定儀市場趨勢

智慧型互聯設備投資增加

對數位健康和​​互聯肺功能測定解決方案的投資增加正在推動市場成長。 各公司正在開發支援藍牙連接、整合人工智慧的肺活量計，用於遠端監測。

例如，2023年1月，Aluna 獲得了1530萬美元的B輪融資，用於擴展其應用程式連接的肺活量計解決方案，以用於氣喘、慢性阻塞性肺病和囊性纖維化管理。同樣，Clario 和 ArtiQ 等公司於2023年3月達成的合作，正在加強人工智慧驅動的肺活量計數據分析在臨床試驗中的應用。

智慧肺活量計的引進已被證實可以減少氣喘相關的急診就診和住院次數，從而進一步增強了產品需求。

市場成長驅動因素

加速技術進步

技術創新是成長的主要驅動力。便攜式、手持式和用戶友好的肺活量計設備解決了利用率低的問題。 2020年1月，NuvoAir的連網肺活量計獲得美國FDA核准，實現了遠端肺功能監測。

人工智慧（AI）的整合進一步提高了診斷準確性並優化了治療方案。持續的研發投入可望改善慢性阻塞性肺病（COPD）的早期檢測和疾病管理效果。

COPD發生率呈上升趨勢

COPD是全球第三大死因。根據美國國家心肺血液研究所（2022年）統計，約有1,600萬美國人患有COPD。吸煙、污染和環境暴露是主要致病因素。全球呼吸系統疾病負擔的加重顯著推高了肺活量測定的需求。

限制因子

熟練專業人員短缺

一個主要的限制因素是訓練有素的肺功能測試人員短缺。 根據世界衛生組織（WHO，2023）的預測，到2030年，全球可能出現1000萬醫護人員的缺口，尤其是在低收入國家。發展中地區熟練勞動力短缺和醫療意識薄弱可能是設備普及應用的障礙。

細分市場分析

依產品類型

該市場依產品類型細分為設備、軟體和配件/耗材。

  • 設備細分市場佔最大佔有率，達52.75%，這主要得益於對先進診斷設備需求的成長。
  • 由於數位醫療的普及，軟體細分市場預計將顯著成長。
  • 由於設備零件可重複使用，配件/耗材的需求保持穩定。

依類型

此市場依類型分為容積式肺活量計和峰值流量計。

  • 預計到 2026 年，容積式肺活量計市佔率將達到 47.71%，這主要得益於其測量結果的準確性和廣泛的臨床應用。
  • 由於無線和便攜式解決方案的日益普及，峰值流量計的市場佔有率也在增長。

依應用

應用領域包括慢性阻塞性肺病 (COPD)、氣喘和其他疾病。

  • 預計到 2026 年，COPD 應用領域市佔率將達到 45.38%，主要得益於該疾病盛行率的上升。
  • 氣喘仍然是一個主要因素，尤其是在兒童。

依最終使用者劃分

市場依最終用戶劃分為醫院、診斷中心、家庭醫療保健、診所和其他。

  • 預計到 2026 年，醫院細分市場將佔 35.34% 的市場佔有率，這主要得益於醫療保健支出的成長。
  • 由於患者對遠端監測解決方案的偏好，家庭醫療保健細分市場正呈現快速成長。

區域洞察

北美

預計到 2025 年，北美市場規模將達到 3.4307 億美元，佔 50.46% 的主導佔有率。慢性阻塞性肺病 (COPD) 和氣喘的高發病率、強有力的監管支持以及主要廠商的存在，正在推動該地區的成長。 預計2026年，美國市場規模將達到3.2453億美元。

歐洲

由於認知度提高和監管審批的推進，歐洲市場預計將穩定成長。預計2026年，英國市場規模將達3,773萬美元，德國市場規模將達2,412萬美元。

亞太地區

由於投資增加和產品發布，預計亞太地區將實現強勁成長。 預計2026年，日本市場規模將達到1,940萬美元，中國市場規模將達到2,685萬美元，印度市場規模將達到2,508萬美元。

世界其他地區

拉丁美洲和中東及非洲地區的市場佔有率相對較小，但正在透過培訓計畫和宣傳活動不斷改善。

目錄

第一章 引言

第二章 摘要整理

第三章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章 主要發現

  • 主要國家和地區呼吸系統疾病盛行率（2025 年）
  • 主要公司新產品發布
  • 主要產業趨勢－併購與合作
  • 主要國家和地區的監管狀況
  • 肺活量計相關技術進步
  • 遠端肺活量測定－定性和定量洞察
  • 新冠疫情對市場的影響

第五章 全球肺活量計市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 設備
    • 軟體
    • 配件和耗材
  • 市場分析、洞察與預測：依類型劃分
    • 容積測量
    • 峰值流量計
  • 市場分析、洞察與預測：依應用劃分
    • 慢性阻塞性肺病 (COPD)
    • 氣喘
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院
    • 診斷中心
    • 家庭醫療保健
    • 醫生/初級保健診所
    • 其他機構
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美肺活量計市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲肺活量計市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲地區

第八章 亞太地區肺活量計市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第九章 拉丁美洲肺活量計市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章 分析中東與非洲肺活量計市場：洞察與預測（2021-2034）

  • 各國市場分析
    • 海灣合作委員會 (GCC)
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • ndd Medizintechnik AG
    • COSMED srl
    • MGC Diagnostics Corporation
    • Morgan Scientific
    • Chest M.I., Inc.
    • VYAIRE
    • Ganshorn Medizin Electronic GmbH
    • Medical International Research (MIR)
Product Code: FBI100486

Growth Factors of spirometer Market

The global spirometer market size was valued at USD 679.85 million in 2025. The market is projected to grow from USD 716.61 million in 2026 to USD 1,122.92 million by 2034, exhibiting a CAGR of 6.63% during the forecast period (2026-2034).

North America dominated the spirometer market with a 50.46% market share in 2025, supported by high respiratory disease prevalence and strong healthcare infrastructure.

A spirometer is a diagnostic medical device used to measure lung function by assessing the volume of air inhaled and exhaled. It plays a crucial role in diagnosing and managing respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. According to the Forum of International Respiratory Societies (2023), around 334 million people suffer from asthma globally, and more than 65 million people are affected by COPD, highlighting the growing demand for spirometry devices.

Although the COVID-19 pandemic negatively impacted the market due to temporary closures of pulmonary function testing (PFT) labs, recovery began in 2021-2022 with the reopening of healthcare facilities and rising demand for respiratory diagnostics.

SPIROMETER MARKET TRENDS

Growing Investment in Smart and Connected Devices

Rising investments in digital health and connected spirometry solutions are driving market growth. Companies are developing Bluetooth-enabled and AI-integrated spirometers for remote monitoring.

For instance, in January 2023, Aluna secured USD 15.3 million in Series B funding to expand its app-connected spirometry solution for asthma, COPD, and cystic fibrosis management. Similarly, partnerships such as Clario and ArtiQ (March 2023) are enhancing AI-driven spirometry data analysis in clinical trials.

The adoption of smart spirometers has shown a reduction in emergency visits and hospitalizations related to asthma, further strengthening product demand.

MARKET GROWTH FACTORS

Increasing Technological Advancements

Technological innovation is a key growth driver. Portable, handheld, and user-friendly spirometry devices have addressed underutilization challenges. In January 2020, NuvoAir's connected spirometer received FDA approval in the U.S., enabling remote lung monitoring.

Artificial intelligence integration is further improving diagnostic accuracy and treatment optimization. Continuous R&D investments are expected to support early COPD detection and improve disease management outcomes.

Rising Prevalence of COPD

COPD is the third leading cause of death worldwide. According to the National Heart, Lung, and Blood Institute (2022), approximately 16 million Americans suffer from COPD. Smoking, pollution, and environmental exposures are major contributors. The growing global burden of respiratory diseases is significantly boosting demand for spirometry testing.

RESTRAINING FACTORS

Shortage of Skilled Professionals

A major limitation is the shortage of trained pulmonary function technologists. According to WHO (2023), there could be a shortfall of 10 million healthcare workers by 2030, particularly in low-income countries. Limited skilled workforce and lack of awareness in developing regions may restrict device adoption.

SEGMENTATION ANALYSIS

By Product Type

The market is segmented into devices, software, and accessories & consumables.

  • The devices segment dominated with a 52.75% share, driven by increasing demand for advanced diagnostic equipment.
  • The software segment is expected to grow significantly due to digital health adoption.
  • Accessories & consumables maintain steady demand due to reusable device components.

By Type

The market includes volume measurement spirometers and peak flow meters.

  • The volume measurement segment held 47.71% share in 2026, owing to accurate results and wide clinical applications.
  • Peak flow meters are growing due to increasing availability of wireless and portable solutions.

By Application

Segments include COPD, asthma, and others.

  • The COPD segment accounted for 45.38% share in 2026, driven by increasing disease prevalence.
  • Asthma remains a major contributor, especially among children.

By End User

The market is segmented into hospitals, diagnostic centers, homecare settings, clinics, and others.

  • The hospitals segment is projected to hold 35.34% share in 2026, supported by rising healthcare expenditure.
  • Homecare settings are witnessing rapid growth due to patient preference for remote monitoring solutions.

REGIONAL INSIGHTS

North America

North America recorded a market size of USD 343.07 million in 2025 and held a dominant 50.46% share. High COPD and asthma prevalence, strong regulatory support, and presence of major players drive regional growth. The U.S. market is projected to reach USD 324.53 million in 2026.

Europe

Europe is projected to grow steadily due to increasing awareness and regulatory approvals. The UK market is projected to reach USD 37.73 million in 2026, while Germany is expected to reach USD 24.12 million in 2026.

Asia Pacific

Asia Pacific is anticipated to witness strong growth due to increasing investments and product launches. The Japan market is projected to reach USD 19.4 million in 2026, China USD 26.85 million, and India USD 25.08 million.

Rest of the World

Latin America and the Middle East & Africa hold comparatively smaller shares but are improving through training programs and awareness campaigns.

COMPETITIVE LANDSCAPE

Key companies include ndd Medizintechnik AG, COSMED srl, MGC Diagnostics, Morgan Scientific, VYAIRE, Ganshorn, and MIR. Strategic collaborations, acquisitions, and AI integration initiatives are strengthening competitive positioning. For example, CAIRE Inc. acquired MGC Diagnostics in January 2023 to expand its respiratory diagnostics portfolio.

CONCLUSION

The global spirometer market is set to grow steadily from USD 679.85 million in 2025 to USD 716.61 million in 2026, reaching USD 1,122.92 million by 2034 at a CAGR of 6.63%. Growth is primarily driven by the increasing prevalence of COPD and asthma, technological advancements in portable and AI-enabled spirometry devices, and expanding home healthcare adoption.

North America remains the leading region with a 50.46% share in 2025, while Asia Pacific is emerging as a high-growth market. Although workforce shortages and limited awareness in developing countries pose challenges, rising investments, regulatory support, and digital health integration are expected to unlock long-term opportunities.

Segmentation By Product Type

  • Devices
  • Software
  • Accessories & Consumables

By Type

  • Volume Measurement
  • Peak Flow Meters

By Application

  • Chronic Obstructive Pulmonary Disorder (COPD)
  • Asthma
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Physician/Primary Care Offices or Clinics
  • Other Facilities

By Region

  • North America (By Product Type, By Type, By Application, By End-User, By Country)
    • U.S. (By Type)
    • Canada (By Type)
  • Europe (By Product Type, By Type, By Application, By End-User, By Country/Sub-Region)
    • U.K. (By Type)
    • Germany (By Type)
    • France (By Type)
    • Italy (By Type)
    • Spain (By Type)
    • Scandinavia (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
    • Japan (By Type)
    • China (By Type)
    • India (By Type)
    • Australia (By Type)
    • Southeast Asia (By Type)
    • Rest of the Asia Pacific (By Type)
  • Latin America (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
    • Brazil (By Type)
    • Mexico (By Type)
    • Rest of Latin America (By Type)
  • Middle East & Africa (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
    • GCC (By Type)
    • South Africa (By Type)
    • Rest of the Middle East & Africa (By Type)

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Respiratory Disorders, By Key Countries/Regions, 2025
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Regulatory Scenario, By Key Countries/Regions
  • 4.5. Technological Advancements Pertaining to Spirometer
  • 4.6. Telespirometry - Qualitative and Quantitative Insights
  • 4.7. Impact of COVID-19 on the Market

5. Global Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Devices
    • 5.1.2. Software
    • 5.1.3. Accessories & Consumables
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Volume Measurement
    • 5.2.2. Peak Flow Meters
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 5.3.2. Asthma
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals
    • 5.4.2. Diagnostic Centers
    • 5.4.3. Homecare Settings
    • 5.4.4. Physician/Primary Care Offices or Clinics
    • 5.4.5. Other Facilities
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Devices
    • 6.1.2. Software
    • 6.1.3. Accessories & Consumables
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Volume Measurement
    • 6.2.2. Peak Flow Meters
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 6.3.2. Asthma
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Homecare Settings
    • 6.4.4. Physician/Primary Care Offices or Clinics
    • 6.4.5. Other Facilities
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Type
    • 6.5.2. Canada
      • 6.5.2.1. By Type

7. Europe Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Devices
    • 7.1.2. Software
    • 7.1.3. Accessories & Consumables
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Volume Measurement
    • 7.2.2. Peak Flow Meters
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 7.3.2. Asthma
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals
    • 7.4.2. Diagnostic Centers
    • 7.4.3. Homecare Settings
    • 7.4.4. Physician/Primary Care Offices or Clinics
    • 7.4.5. Other Facilities
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Type
    • 7.5.2. Germany
      • 7.5.2.1. By Type
    • 7.5.3. France
      • 7.5.3.1. By Type
    • 7.5.4. Italy
      • 7.5.4.1. By Type
    • 7.5.5. Spain
      • 7.5.5.1. By Type
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Type
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Type

8. Asia Pacific Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Devices
    • 8.1.2. Software
    • 8.1.3. Accessories & Consumables
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Volume Measurement
    • 8.2.2. Peak Flow Meters
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 8.3.2. Asthma
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Homecare Settings
    • 8.4.4. Physician/Primary Care Offices or Clinics
    • 8.4.5. Other Facilities
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Type
    • 8.5.2. China
      • 8.5.2.1. By Type
    • 8.5.3. India
      • 8.5.3.1. By Type
    • 8.5.4. Australia
      • 8.5.4.1. By Type
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Type
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Type

9. Latin America Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Devices
    • 9.1.2. Software
    • 9.1.3. Accessories & Consumables
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Volume Measurement
    • 9.2.2. Peak Flow Meters
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 9.3.2. Asthma
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals
    • 9.4.2. Diagnostic Centers
    • 9.4.3. Homecare Settings
    • 9.4.4. Physician/Primary Care Offices or Clinics
    • 9.4.5. Other Facilities
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Type
    • 9.5.2. Mexico
      • 9.5.2.1. By Type
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Type

10. Middle East & Africa Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Devices
    • 10.1.2. Software
    • 10.1.3. Accessories & Consumables
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Volume Measurement
    • 10.2.2. Peak Flow Meters
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 10.3.2. Asthma
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Centers
    • 10.4.3. Homecare Settings
    • 10.4.4. Physician/Primary Care Offices or Clinics
    • 10.4.5. Other Facilities
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Type
    • 10.5.2. South Africa
      • 10.5.2.1. By Type
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. ndd Medizintechnik AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. COSMED srl
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. MGC Diagnostics Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Morgan Scientific
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Chest M.I., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. VYAIRE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Ganshorn Medizin Electronic GmbH
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medical International Research (MIR)
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 3: Global Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 4: Global Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 5: Global Spirometer Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 7: North America Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 8: North America Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 9: North America Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 10: North America Spirometer Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: U.S. Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 12: Canada Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 13: Europe Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 15: Europe Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 16: Europe Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 17: Europe Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: U.K. Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 19: Germany Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 20: France Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 21: Italy Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 22: Spain Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 23: Scandinavia Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 24: Rest of Europe Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 25: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 29: Asia Pacific Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Japan Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 31: China Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 32: India Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 33: Australia Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 34: Southeast Asia Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 35: Rest of Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 36: Latin America Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 37: Latin America Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 38: Latin America Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 39: Latin America Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 40: Latin America Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 42: Mexico Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 43: Rest of Latin America Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 44: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 45: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 46: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 47: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 48: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 50: South Africa Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 51: Rest of Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034

List of Figures

  • Figure 1: Global Spirometer Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Spirometer Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Spirometer Market Value Share (%), by Type, 2025 & 2034
  • Figure 4: Global Spirometer Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Spirometer Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Spirometer Market Value (USD million), by Region, 2025 & 2034
  • Figure 7: North America Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 8: North America Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 9: North America Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 10: North America Spirometer Market Value Share (%), by Type, 2025
  • Figure 11: North America Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 12: North America Spirometer Market Value Share (%), by Application, 2025
  • Figure 13: North America Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 14: North America Spirometer Market Value Share (%), by End User, 2025
  • Figure 15: North America Spirometer Market Value (USD million), By Country, 2025 & 2034
  • Figure 16: North America Spirometer Market Value Share (%), By Country, 2025
  • Figure 17: Europe Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 18: Europe Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 19: Europe Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 20: Europe Spirometer Market Value Share (%), by Type, 2025
  • Figure 21: Europe Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 22: Europe Spirometer Market Value Share (%), by Application, 2025
  • Figure 23: Europe Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 24: Europe Spirometer Market Value Share (%), by End User, 2025
  • Figure 25: Europe Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 28: Asia Pacific Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 29: Asia Pacific Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 30: Asia Pacific Spirometer Market Value Share (%), by Type, 2025
  • Figure 31: Asia Pacific Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Spirometer Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Spirometer Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 38: Latin America Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 39: Latin America Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 40: Latin America Spirometer Market Value Share (%), by Type, 2025
  • Figure 41: Latin America Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 42: Latin America Spirometer Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 44: Latin America Spirometer Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 48: Middle East & Africa Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 49: Middle East & Africa Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 50: Middle East & Africa Spirometer Market Value Share (%), by Type, 2025
  • Figure 51: Middle East & Africa Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Spirometer Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Spirometer Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Spirometer Market Share (%), By Company, 2025